Altria is executing a pivot to smoke-free products with regulatory approval for new on!-branded nicotine pouches. The company maintains equity investments in Anheuser-Busch InBev, the world's largest brewer, and Cronos Group, a leading Canadian cannabinoid company. With an adjusted EPS payout ratio of approximately 76% in 2026, the company maintains capital flexibility for new category investments and dividend growth.
Cyborg Score Rationale
Altria forecasts mid-single-digit EPS CAGR through 2028 with continued dividend growth, but faces secular declines in traditional combustible categories. CEO transition with Salvatore Mancuso assuming leadership effective May 14, 2026, provides fresh strategic direction. The company's strong cash generation and dividend yield are offset by structural headwinds in combustible products.
Top Insights
2026 EPS guidance of $5.56-$5.72 represents 2.5%-5.5% growth from 2025 base of $5.42
CEO Billy Gifford retiring May 2026; Salvatore Mancuso promoted from CFO to succeed him
Regulatory wins including approval for six new on!-branded nicotine pouches support smoke-free transition
Global collaboration MOU with KT&G Corporation targeting modern oral nicotine products, non-nicotine products, and operational efficiency
Named Competitors
iQOS — Heat-not-burn tobacco products
Vuse — E-vapor products
General Brands — Global tobacco and nicotine portfolio
Recent Developments
(January 2026) 2026 EPS guidance provided: $5.56-$5.72 range with 2.5%-5.5% growth
(January 2026) CEO succession announced; Mancuso to replace Gifford effective May 2026
(January 2026) Global collaboration MOU signed with KT&G Corporation for nicotine and non-nicotine products
(2025) $2.2 billion impairment charges taken in e-vapor segment; Proper Wild achieved 25,000+ store distribution
Open the full interactive Altria Group, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.